Recall Register

Drug recall: Hydrocortisone Butyrate Cream 0.1%, Net Wt. 15 gm tubes, Rx only, Manufactured for: Rouses Point Pharmaceuticals, LLC…

Class III FDA enforcement event 69359. Recall start date: . Status in the FDA record: Terminated. Termination date: .

Reason for recall, in the words of FDA

Subpotent Drug; for the active, HCB, and preservatives, Propylparaben and Butylparaben at the 18 month stability test point

Class III, in the words of FDA

a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences

Valeant Pharmaceuticals International started this drug recall on 2 Oct 2014. The firm address in the FDA record is in Bridgewater, NJ. FDA put the recall in Class III. FDA event 69359 has 2 product records. The first FDA enforcement report date is 22 Oct 2014. The record gives the status Terminated, with the termination date 3 Apr 2015.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

Nationwide and Puerto Rico

Recalling firm

Valeant Pharmaceuticals International, Bridgewater, NJ.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

2 product records in the event.

FDA event 69359: product records
Recall numberProductQuantityClassStatusReport date
D-0025-2015Hydrocortisone Butyrate Cream 0.1%, Net Wt. 15 gm tubes, Rx only, Manufactured for: Rouses Point Pharmaceuticals, LLC Cranford, NJ 07016 By: Ferndale Laboratories, Inc. Ferndale, MI 48220 --- NDC 43478-270-1534,218 tubesClass IIITerminated22 Oct 2014
D-0026-2015Locoid (hydrocortisone butyrate 0.1%), Cream, Net Wt. 15 gm tubes, Rx only, Manufactured for: Onset Dermatologics, LLC, Cumberland, RI 02864 By: Ferndale Laboratories, Inc. Ferndale, MI 48220 --- NDC 16781-382-151663 tubesClass IIITerminated22 Oct 2014

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class III: The lowest of the three FDA recall classes.

The event in context

Drug events that started in 2014
313
Share of these events in Class III
27%
Product records in this event
2
Events of the firm on the register
1

Official channels

Cite this page

Recall Register. FDA enforcement event 69359. https://recallregister.com/fda/iii/69359/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA drug enforcement reports
Licence
CC0 1.0
Export date
28 Sep 2026
Newest FDA report date on the register
23 Sep 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: Nationwide and Puerto Rico
What quantity of product is in FDA event 69359?
The event has 2 product records. The first record gives this quantity: 34,218 tubes
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many drug recalls of 2014 have the same class?
27% of the 313 drug events that started in 2014 are in Class III.